National Research Stock (NASDAQ:NRC)


RevenueOwnershipFinancialsChartTranscripts

Previous Close

$21.28

52W Range

$11.01 - $22.79

50D Avg

$18.29

200D Avg

$16.47

Market Cap

$423.46M

Avg Vol (3M)

$112.84K

Beta

0.40

Div Yield

$0.56 (2.98%)

NRC Company Profile


National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

368

IPO Date

May 23, 2013

Website

NRC Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceJun 23Mar 23Dec 22Sep 22
CANADA----
UNITED STATES$36.16M$36.47M$38.14M$37.69M

Fiscal year ends in Dec 25 | Currency in USD

NRC Financial Summary


Dec 25Dec 24Dec 23
Revenue$137.39M$143.06M$148.58M
Operating Income$22.59M$35.19M$40.05M
Net Income$11.60M$24.78M$30.97M
EBITDA$30.23M$41.31M$45.98M
Basic EPS$0.52$1.05$1.26
Diluted EPS$0.52$1.04$1.25

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts


Q4 25Feb 03, 26 | 12:00 AM
Q1 24May 08, 24 | 11:00 AM
Q4 23Feb 14, 24 | 11:00 AM

Peer Comparison


TickerCompany
SNWVSANUWAVE Health, Inc.
QTRXQuanterix Corporation
NNOXNano-X Imaging Ltd.
VMDViemed Healthcare, Inc.
TBRGTruBridge, Inc.
SPOKSpok Holdings, Inc.
PBYIPuma Biotechnology, Inc.
SOPHSOPHiA GENETICS S.A.
DHDefinitive Healthcare Corp.
HCATHealth Catalyst, Inc.